Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.
Copyright 2024 – Finance News Network
Source: Finance News Network
08 Jun 2021 - MLC Asset Management Senior Economist Bob Cunneen discusses factors behind gains in the global economy and the Australian market over May.
Read More10 Jul 2024 - Santana Minerals Limited (ASX:SMI) CEO Damian Spring provides an update on the company's progress, discussing an increase in indicated resource at the RAS deposit, expected completion of the prefeasibility study, stakeholder engagement, and the possible impact of the Fast-Track Approvals Bill.
Read More27 May 2025 - The structure and portfolio advantages of investing in LICs.
Read More11 Aug 2020 - Regeneus (ASX:RGS) CEO, Leo Lee talks about its collaboration with Kyocera of Japan to market Progenza its cell therapy treatment for anti-inflammatory treatment and repair of damaged or diseased tissue.
Read More16 March 2022 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen discusses the acquisition of Synchron and what this means for WT.
Read More23 Apr 2021 - Capral Limited (ASX:CAA) Managing Director Tony Dragicevich talks about the company's strong FY20 results despite COVID, its product mix, operating environment and outlook.
Read More13 Mar 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker talks 1H20 results progress with the company's lead product Zolpimist, the spay version of Sanofi’s blockbuster insomnia drug Ambien and focus for 2020.
Read More12 Oct 2023 - QX Resources (ASX:QXR) CEO Steve Promnitz discusses recent funding success and promising prospects for Liberty Lithium Brine Project.
Read More06 Nov 2019 - Immutep Limited (ASX:IMM) CEO, Marc Voigt provides an update on the company's clinical trial data for its Phase 1 trial in melanoma, TACTI-mel, where patients are responding positively to the combination therapy of efti and Keytruda.
Read More21 Aug 2020 - DigitalX Limited (ASX:DCC) Executive Director Leigh Travers provides an update on the company's strategy, its focus on blockchain consulting and development for the enterprise market and digital asset management, the impact of COVID-19, and priorities.
Read More
